Drug Discovery & Development
The objective of the Master of Business & Science with a concentration in Drug Development and Discovery is to provide broad-based training for students in the areas of Drug Discovery, Drug Development, Regulatory Affairs, and Clinical Trials Management. Students will learn about the pharmaceutical development process and acquire analytical and communication skills suitable for managerial and staff positions in laboratory and clinical research, clinical trials, contract research organizations, federal regulatory agencies – such as the FDA - and pharmaceutical marketing.
A number of our concentrations are geared towards professionals who have experience in their respective fields but are interested in enhancing their scientific and business knowledge. Many courses in these concentrations are either online or exec-style (concentrated curriculum). Please contact our office for more information.
A total of 24 credits are required in the science curriculum. Five courses are required, all of which are for 3 credits each. Descriptions of some of the required Science Courses can be found here:
* 16:137:510 Drug Development from Concept to Market (3 cr) (Fall)
* 16:137:603 Fundamentals of Biological Chemistry in the Biotech Industry (3 cr) (Fall)
* Take 2 of the following 3 courses:
16:137:580 Practical Aspects of Clinical Trial Design/Conduct (3 cr) (Fall)
16:137:582 Fundamentals of Regulatory Affairs (3 cr) (Spring)
16:137:581 Statistics in Clinical and Translational Research (3 cr) (Spring)
In addition, students are required to take the following course – given in the summer only- as part of their science or business electives:
Fundamentals of Intellectual Property (16:137:501) (3cr)
Note: 6 credits (3 Science/3 Business) can be earned in an Internship.